
Amgen Inc. is a leading multinational biotechnology company headquartered in Thousand Oaks, California, USA. Founded in 1980, Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its mission is to serve patients by transforming scientific discoveries into medicines that improve lives, with a focus on areas such as oncology, cardiovascular disease, neuroscience, and inflammation. The company is recognized for pioneering biologics and leveraging advanced genetic research to address serious illnesses.
With over 25,000 employees worldwide, Amgen holds a strong position in the global biotech market, consistently ranking among the largest biotechnology firms by revenue. It has a diverse portfolio of approved medicines, including well-known biologics like Enbrel, Neulasta, and Prolia, as well as a robust pipeline of investigational therapies. Recently, Amgen has made headlines for strategic acquisitions, such as its purchase of Horizon Therapeutics in 2023, expanding its rare disease portfolio, and for advancing cutting-edge research in biosimilars and precision medicine. The company is also committed to sustainability and corporate responsibility, aiming to reduce its environmental footprint while maintaining high standards of scientific excellence.

Amgen • Hyderabad
₹6L - ₹10L LPA
9 months ago

Amgen • Bangalore
₹4.5L - ₹9L LPA
11 months ago

Amgen • Hyderabad
₹10L - ₹10L LPA
1 year ago